<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BPMC
Blueprint Medicines
$
()


  • Cogent Biosciences price target raised by $2 at Citi, here's why

    2/26/2024 - 06:37am
  • Blueprint Medicines announces PIONEER trial results

    2/23/2024 - 08:08am
  • Blueprint Medicines price target raised by $5 at Needham, here's why

    2/16/2024 - 09:29am
  • Blueprint Medicines price target lowered by $8 at Wells Fargo, here's why

    2/16/2024 - 07:49am
  • Blueprint Medicines price target raised by $11 at Citi, here's why

    2/16/2024 - 06:54am
  • Blueprint Medicines price target raised by $40 at H.C. Wainwright, here's why

    2/16/2024 - 06:09am
  • Blueprint Medicines price target raised by $9 at Oppenheimer, here's why

    2/15/2024 - 15:07pm
  • Blueprint Medicines provides 2024 financial guidance

    2/15/2024 - 07:10am
  • Blueprint Medicines reports Q4 EPS ($1.82), consensus ($2.04)

    2/15/2024 - 07:09am
  • Blueprint Medicines price target raised by $12 at Barclays, here's why

    2/13/2024 - 05:11am
  • Blueprint Medicines price target raised by $5 at Oppenheimer, here's why

    1/30/2024 - 22:17pm
  • Blueprint Medicines price target raised by $20 at Piper Sandler, here's why

    1/19/2024 - 07:43am
  • Blueprint Medicines says AYVAKIT has potential to be multibillion-dollar therapy

    1/9/2024 - 17:09pm
  • Blueprint Medicines price target raised by $25 at Goldman Sachs, here's why

    1/9/2024 - 17:07pm
  • Blueprint Medicines price target raised by $2 at Stifel, here's why

    1/9/2024 - 08:57am
dynamic_feed Breaking News